Procter & Gamble Hygiene and Health Care · NSE: PGHH · BSE: 500459
Q4 FY22 results · Jan–Mar 2022
Procter & Gamble Hygiene and Health Care reported revenue from operations of ₹973.26 crore (up 28.1% from Q4 FY21) and net profit of ₹102.85 crore (up 4.6% from Q4 FY21) for Q4 FY22 (Jan–Mar 2022), on a standalone basis.
| Item | Q4 FY22 | Q4 FY21 | YoY | Q3 FY22 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 973.26 | 759.66 | +28.1% | 1,092.98 | −11.0% |
| Other income | 6.03 | 14.75 | −59.1% | 6.86 | −12.1% |
| Total income | 979.29 | 774.41 | +26.5% | 1,099.84 | −11.0% |
| Profit before tax | 151.10 | 129.23 | +16.9% | 287.50 | −47.4% |
| Net profit for the period | 102.85 | 98.33 | +4.6% | 212.06 | −51.5% |
| EPS, basic (₹) | 31.68 | 30.29 | +4.6% | 65.33 | −51.5% |
| Net margin (%) | 10.6 | 12.9 | 19.4 |
Standalone
- Filed with BSE
- 28 Apr 2022, 18:18 IST
- Board meeting
- 28 Apr 2022
- Period
- 01 Jan 2022 to 31 Mar 2022
- Review status
- Unaudited
- Source
- XBRL filing on BSE